Ennogen Pharma Ltd

POWER SEARCH PRICING

SOLUTIONS

ennogen pharma ltd Company Information

Live

EstablishedSmallDeclining

Company Number

07751819

Website

www.ennogen.com

Registered Address

unit g4, riverside industrial estate, dartford, kent, DA1 5BS

Industry

Wholesale of pharmaceutical goods

Manufacture of basic pharmaceutical products

Telephone

01322629220

Next Accounts Due

September 2024

Group Structure

View All

Directors

Gurdev Ruprai13 Years

Shareholders

gurdev singh ruprai 100%

ennogen pharma ltd Estimated Valuation

£3.8m

Pomanda estimates the enterprise value of ENNOGEN PHARMA LTD at £3.8m based on an EBITDA of £741k and a 5.07x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Ennogen Pharma Ltd is a live company located in dartford, DA1 5BS with a Companies House number of 07751819. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in August 2011, it's largest shareholder is gurdev singh ruprai with a 100% stake. Ennogen Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.9m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Ennogen Pharma Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating5out of 5

5 Strong

2 Regular

4 Weak

Size

annual sales of £1.9m, make it smaller than the average company (£28.3m)

Growth

3 year (CAGR) sales growth of -45%, show it is growing at a slower rate (4.1%)

EXPORT

Ennogen Pharma Ltd's latest turnover from December 2022 is estimated at £1.9 million and the company has net assets of £1.6 million. According to their latest financial statements, Ennogen Pharma Ltd has 2 employees and maintains cash reserves of £161.8 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012
Turnover	1,882,086	2,386,879	1,831,708	11,439,106	7,838,375	2,458,127	3,119,922	2,516,710	10,725,612	3,221,525	1,181,118
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,273,255	1,589,963	1,224,793	7,675,208	5,203,229	1,650,833	2,075,395	1,672,379	7,231,071	2,187,090	807,989
Gross Profit	608,831	796,916	606,915	3,763,899	2,635,146	807,294	1,044,527	844,332	3,494,540	1,034,435	373,130
Admin Expenses	-132,187	694,344	261,557	3,679,565	2,535,282	449,246	543,626	781,523	3,422,467	1,103,785	374,757
Operating Profit	741,018	102,572	345,358	84,334	99,864	358,048	500,901	62,809	72,073	-69,350	-1,627
Interest Payable	0	0	0	15,000	62,863	140,911	91,174	0	0	0	0
Interest Receivable	3,682	96	43	593	694	1,574	760	466	974	1,410	743
Pre-Tax Profit	744,700	102,668	345,401	69,927	37,695	218,711	410,488	63,275	73,047	-67,940	-884
Tax	-141,493	-19,507	-65,626	-13,286	-7,162	-41,555	-82,097	-12,655	-15,340	0	0
Profit After Tax	603,207	83,161	279,775	56,641	30,533	177,156	328,390	50,620	57,707	-67,940	-884
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	603,207	83,161	279,775	56,641	30,533	177,156	328,390	50,620	57,707	-67,940	-884
Employee Costs	130,513	247,489	427,373	424,741	404,360	497,043	475,790	710,562	1,702,554	500,418	180,041
Number Of Employees	2	4	7	7	7	9	9	14	35	11	4
EBITDA*	741,018	102,572	345,425	84,423	99,982	358,206	501,000	62,809	72,073	-69,350	-1,627

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012
Tangible Assets	0	0	198	265	354	472	299	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	1,682,960	0	0	0
Total Fixed Assets	0	0	198	265	354	472	299	1,682,960	0	0	0
Stock & work in progress	0	650,669	1,050,476	1,387,246	1,117,787	959,916	507,501	373,140	379,213	600,413	57,601
Trade Debtors	232,962	399,246	106,962	3,624,245	1,612,444	244,841	737,176	313,383	1,750,159	201,459	91,706
Group Debtors	2,153,212	476,466	0	1,218,658	1,218,658	1,196,658	1,682,960	0	0	0	0
Misc Debtors	208,082	431,444	310,652	0	0	0	20,247	0	0	0	0
Cash	161,755	48,653	27,802	58,465	99,644	85,346	544,109	63,803	122,526	267,075	297,082
misc current assets	0	0	0	0	0	0	0	0	0	0	0
total current assets	2,756,011	2,006,478	1,495,892	6,288,614	4,048,533	2,486,761	3,491,993	750,326	2,251,898	1,068,947	446,389
total assets	2,756,011	2,006,478	1,496,090	6,288,879	4,048,887	2,487,233	3,492,292	2,433,286	2,251,898	1,068,947	446,389
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	613,141	435,381	191,539	522,674	1,903,123	260,180	59,845	70,590	2,262,915	1,137,671	447,173
Group/Directors Accounts	9,474	223,982	175,527	4,822,589	717,313	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	534,930	351,856	216,926	311,293	408,326	263,747	146,897	52,868	0	0	0
total current liabilities	1,157,545	1,011,219	583,992	5,656,556	3,028,762	523,927	206,742	123,458	2,262,915	1,137,671	447,173
loans	0	0	0	0	444,443	1,418,157	2,917,557	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	2,270,225	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	444,443	1,418,157	2,917,557	2,270,225	0	0	0
total liabilities	1,157,545	1,011,219	583,992	5,656,556	3,473,205	1,942,084	3,124,299	2,393,683	2,262,915	1,137,671	447,173
net assets	1,598,466	995,259	912,098	632,323	575,682	545,149	367,993	39,603	-11,017	-68,724	-784
total shareholders funds	1,598,466	995,259	912,098	632,323	575,682	545,149	367,993	39,603	-11,017	-68,724	-784

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012
Operating Activities
Operating Profit	741,018	102,572	345,358	84,334	99,864	358,048	500,901	62,809	72,073	-69,350	-1,627
Depreciation	0	0	67	89	118	158	99	0	0	0	0
Amortisation	0	0	0	0	0	0	0	0	0	0	0
Tax	-141,493	-19,507	-65,626	-13,286	-7,162	-41,555	-82,097	-12,655	-15,340	0	0
Stock	-650,669	-399,807	-336,770	269,459	157,871	452,415	134,361	-6,073	-221,200	542,812	57,601
Debtors	1,287,100	889,542	-4,425,289	2,011,801	1,389,603	-998,884	444,040	246,184	1,548,700	109,753	91,706
Creditors	177,760	243,842	-331,135	-1,380,449	1,642,943	200,335	-10,745	-2,192,325	1,125,244	690,498	447,173
Accruals and Deferred Income	183,074	134,930	-94,367	-97,033	144,579	116,850	94,029	52,868	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	323,928	-27,898	4,616,356	-3,687,605	332,868	1,180,305	-76,214	-2,329,414	-145,523	-31,417	296,239
Investing Activities
capital expenditure	0	198	0	0	0	-331	-398	0	0	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	0	198	0	0	0	-331	-398	0	0	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	-214,508	48,455	-4,647,062	4,105,276	717,313	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	-444,443	-973,714	-1,499,400	2,917,557	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	-2,270,225	2,270,225	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	100
interest	3,682	96	43	-14,407	-62,169	-139,337	-90,414	466	974	1,410	743
cash flow from financing	-210,826	48,551	-4,647,019	3,646,426	-318,570	-1,638,737	556,918	2,270,691	974	1,410	843
cash and cash equivalents
cash	113,102	20,851	-30,663	-41,179	14,298	-458,763	480,306	-58,723	-144,549	-30,007	297,082
overdraft	0	0	0	0	0	0	0	0	0	0	0
change in cash	113,102	20,851	-30,663	-41,179	14,298	-458,763	480,306	-58,723	-144,549	-30,007	297,082

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for ennogen pharma ltd. Get real-time insights into ennogen pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for ennogen pharma ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in DA1 area or any other competitors across 12 key performance metrics.

ENNOGEN PHARMA LTD group structure

Ennogen Pharma Ltd has no subsidiary companies.

Ultimate parent company

ENNOGEN PHARMA LTD

07751819

ENNOGEN PHARMA LTD Shareholders

gurdev singh ruprai

100%

Ennogen Pharma Ltd currently has 1 director, Mr Gurdev Ruprai serving since Aug 2011.

officer	country	age	start	end	role
Mr Gurdev Ruprai		64 years	Aug 2011	-	Director

P&L

December 2022

turnover

1.9m

-21%

operating profit

741k

gross margin

32.4%

-3.11%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

1.6m

+0.61%

total assets

2.8m

+0.37%

cash

161.8k

+2.32%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

ennogen healthcare ltd

regent pharmaceuticals limited

manx healthcare limited

2.5

principle healthcare limited

elanco uk ah limited

3.5

company number

07751819

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

21100 - Manufacture of basic pharmaceutical products

incorporation date

August 2011

age

accounts

Small Company

ultimate parent company

None

previous names

N/A

incorporated

address

unit g4, riverside industrial estate, dartford, kent, DA1 5BS

last accounts submitted

December 2022

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to ennogen pharma ltd. Currently there are 1 open charges and 1 have been satisfied in the past.

ennogen pharma ltd Company Information

ennogen pharma ltd Estimated Valuation

ennogen pharma ltd Estimated Valuation

ennogen pharma ltd Estimated Valuation

Ennogen Pharma Ltd Overview

Ennogen Pharma Ltd Health Check

ENNOGEN PHARMA LTD financials

ennogen pharma ltd Credit Report and Business Information

Ennogen Pharma Ltd Competitor Analysis

ennogen pharma ltd Ownership

ennogen pharma ltd directors

ennogen pharma ltd company details

ennogen pharma ltd Charges & Mortgages

ennogen pharma ltd Companies House Filings - See Documents